Clinical trial Recruiting at 2 sites Phase 4 Interventional Ages 18 to 65

Single-dose IV magnesium sulfate to reduce pain after laparoscopic gallbladder removal

Official title: Effect of Single Dose Intravenous Magnesium Sulfate on Postoperative Analgesic Consumption in Patients Undergoing Laparoscopic Cholecystectomy

Run by Tata Main Hospital · NCT07328893 · Data updated 2026-11-12

We will try a single IV dose of magnesium sulfate to see if adults having elective laparoscopic gallbladder removal need less morphine after surgery.

More Analgesia trials

Quick facts

PhasePhase 4
Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment106 (estimated)
SponsorTata Main Hospital
Academic / other
Locations2 sites (Jamshedpur, Jharkhand and 1 other locations)
StatusRecruiting
StartedDecember 27, 2025
Main results expectedOctober 31, 2026
Study endsDecember 31, 2026
Registry record updatedJanuary 9, 2026
Trial IDNCT07328893 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with ASA I–II scheduled for elective laparoscopic cholecystectomy who do not have major organ dysfunction and are not on chronic magnesium or calcium-channel blocker therapy.

Probably not a fit

Patients with renal, hepatic, or cardiovascular dysfunction (including conduction disorders), BMI >30, obstructive sleep apnea, long-term calcium channel blocker or magnesium use, opioid/analgesic abuse, psychiatric illness, or whose surgery may be converted to open are excluded and unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized, double-arm trial enrolling 106 adults aged 18–65 with ASA physical status I–II who are scheduled for elective laparoscopic cholecystectomy. Participants are randomized to receive a single IV dose of magnesium sulfate (30 mg/kg in 100 ml normal saline) or placebo (normal saline) alongside standard anesthetic care. The primary outcome is total postoperative morphine consumption, with secondary outcomes including pain scores (VAS), time to first rescue analgesia, hemodynamic responses, and adverse events. Data will be compared between groups using descriptive statistics, chi-square tests, and t-tests or Mann–Whitney U-tests as appropriate.

Why it matters

Potential benefit: If effective, this could reduce the amount of postoperative opioids needed and lower opioid-related side effects after laparoscopic cholecystectomy.

How similar studies have gone: Previous randomized trials and meta-analyses of perioperative IV magnesium have shown modest opioid-sparing effects in various surgical settings, though results have been mixed and depend on dose and context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age - 18 - 65 years, either sex American Society of Anesthesiologists (ASA) Physical status classification system group I and II Elective laparoscopic cholecystectomy

Exclusion Criteria:

Patient refusal BMI \> 30 kg/m² OSA Renal, hepatic or cardiovascular dysfunction including cardiac conduction disorders Those on long term calcium channel blockers or receiving magnesium supplements Opioid or analgesic abuse Psychiatric illness Surgical duration \< 1 h \& \> 3 h Lap converted to open

Where it's running

  • Tata Main Hospital
    Jamshedpur, Jharkhand, India
    Recruiting
  • Dr.Deb Sanjay Nag
    Jamshedpur, Jharkhand, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.